Pelthos Therapeutics Inc. (PTHS) vs VAXART, INC. (VXRT)
Pelthos Therapeutics Inc. and VAXART, INC. are both Biotechnology companies. Pelthos Therapeutics Inc. and VAXART, INC. are of similar size ($92.4M and $85.8M). Pelthos Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (15.9% vs −199.5%) and the higher return on invested capital (134.6% vs −82.3%). Across the 15 metrics below, VAXART, INC. leads on 12 and Pelthos Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | PTHS | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.59% | 100.00% | 65.16% |
| Operating margin | (133.42%) | 16.30% | 0.00% |
| Net margin | (199.50%) | 15.88% | 0.00% |
| Free cash flow margin | (98.37%) | 13.74% | 0.00% |
| Return on equity | 2,161.07% | 66.97% | (57.72%) |
| Return on assets | (125.04%) | 23.44% | (49.22%) |
| Return on invested capital | (82.34%) | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack